|
HS Code |
343060 |
| Product Name | D-(-)-A-4-Hydroxyphenylglycine Dane Salt Methyl Potassium |
| Chemical Formula | C8H8NO3K |
| Molecular Weight | 205.26 g/mol |
| Appearance | White to off-white powder |
| Solubility | Soluble in water |
| Purity | Typically ≥98% |
| Cas Number | 67248-85-3 |
| Storage Temperature | 2-8°C |
| Optical Activity | D-(-)-isomer |
| Usage | Pharmaceutical intermediate |
| Melting Point | Decomposes before melting |
| Synonyms | D-4-Hydroxyphenylglycine potassium salt |
As an accredited D-(-)-A-4-Hydroxyphenylglycine Dane Salt Methyl Potassium factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | White HDPE bottle containing 100g, sealed with a tamper-evident cap, labeled with product name, batch number, and safety information. |
| Shipping | D-(-)-A-4-Hydroxyphenylglycine Dane Salt Methyl Potassium is shipped in tightly sealed, chemical-resistant containers to prevent contamination and moisture exposure. It is packed under cool, dry, and stable conditions, following all applicable hazardous material transport regulations. Proper labeling and documentation are included to ensure safe and regulated handling during transit. |
| Storage | Store D-(-)-A-4-Hydroxyphenylglycine Dane Salt Methyl Potassium in a tightly sealed container in a cool, dry, and well-ventilated area. Protect from light, moisture, and incompatible substances such as strong acids and oxidizers. Keep away from sources of ignition and store at room temperature unless otherwise specified by the manufacturer. Always follow local regulations and material safety data sheet (MSDS) recommendations for safe storage. |
Applications of D-(-)-A-4-Hydroxyphenylglycine Dane Salt Methyl Potassium in Industrial ManufacturingD-(-)-A-4-Hydroxyphenylglycine Dane Salt Methyl Potassium is a key intermediate with targeted applications in specialty chemical synthesis, particularly in high-value pharmaceutical, agrochemical, and chiral auxiliary production lines. As the original manufacturer, we supply this material to industrial processors integrating advanced enantioselective transformations and regulated process environments. 1. Active Pharmaceutical Ingredient (API) Intermediate for Cephalosporin AntibioticsDrug substance manufacturers utilize this raw material in the synthesis of advanced cephalosporin intermediates, especially for side-chain construction in the cephalexin and cefadroxil series. Controlled enantiomeric purity and batch traceability allow direct formulation into chiral intermediates, supporting stringent pharma process validation and final API quality assurance. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Chiral Auxiliary in Asymmetric SynthesisChiral process units rely on this material as a stereochemistry-directing agent to introduce specific enantiomeric centers during fine chemical or pharmaceutical intermediate production. Its well-characterized optical purity supports advanced asymmetric catalysis protocols for regulatory-compliant specialty ingredient manufacturing. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Intermediate for Agrochemical Synthesis — Herbicide Building BlockAgrochemical formulation facilities employ this compound in the development and scaling of selective herbicide molecules. It serves as an integral coupling partner in the formation of phenoxy-based or glycine-derivative herbicidal actives, supporting precise mapping to crop protection compound regulations and active ingredient registration dossiers. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Precursor for Peptide and Amino Acid Derivative ManufacturingPeptide synthesis companies and amino acid derivative producers integrate this substance as a protected glycine analog, ensuring fidelity in segment coupling and N-terminal modification of pharmaceutical peptides and research-grade oligopeptides. Manufacturing protocols utilize its potassium salt form for superior handling and solubility in automated synthesis platforms. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Advanced Intermediate for Fine Chemical Research & Specialty ReagentsSpecialty reagent laboratories and fine chemical innovators apply the material as a scaffold in the preparation of advanced analytical standards, molecular probes, and research agents. Its defined stereochemistry and trace metal content profile attract use in custom projects requiring reproducible performance for regulated analytical and discovery applications. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive D-(-)-A-4-Hydroxyphenylglycine Dane Salt Methyl Potassium prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Every batch of D-(-)-A-4-Hydroxyphenylglycine Dane Salt Methyl Potassium rolling out of our facility reflects a commitment built on years at the bench and on the plant floor. Producing this salt involves a combination of precise control over stereochemistry and strict management of process hygiene. Operators on our production lines track each stage, starting from careful weighing of raw materials through synthesis and purification. This personal attention serves a direct purpose—research teams and industrial chemists depend on accuracy, purity, and reproducibility. Our crew faces the challenges of producing chiral intermediates daily, catching small deviations that could impact downstream applications.
This compound, a potassium salt form of D-(-)-A-4-Hydroxyphenylglycine methyl ester, finds its value not in empty marketing, but in tangible outcomes seen in the lab and at the reactor scale. Our product supports the needs of peptide chemists and pharmaceutical developers who rely heavily on well-defined chiral building blocks. For these teams, each shipment of this material can mean a smoother sequence assembly, less time troubleshooting purification steps, and greater confidence in maintaining optical purity from starting material to final active pharmaceutical ingredient.
People working with this class of molecules are intimately aware that trace levels of by-products, moisture, or racemates do more than chip away at yields—they can halt project timelines altogether. Our operators handle these details every day, using real experience instead of just relying on spec sheets. Documentation alone does not guarantee batch consistency. Our shop floor supervisors track every production lot through repeated spectroscopy and chromatography checks; batch records double as stories of obstacles solved at odd hours.
The model specifications we apply resulted from iterative in-house development and cooperation with our partners in the pharmaceutical sector over many years. D-(-)-A-4-Hydroxyphenylglycine Dane Salt Methyl Potassium, as supplied from our reactors, consistently reaches a chemical purity that exceeds 98% by HPLC, with chiral purity above 99% as checked by polarimetry. Our teams drive down water content to below 0.5% using carefully regulated drying, then seal each package under controlled atmosphere to stop hydrate formation.
Production does not end at the reactor discharge. Every lot comes through our final QC area, where the familiarity between our chemists and both the instrument signals and the subtle physical cues—crystal morphology, dry feel, color—serves as the last quality gate. On average, final lots present as an off-white to beige crystalline solid, with minimal flowability issues due to advanced granulation controls we have been refining in response to customer feedback.
Our longstanding clients in pharmaceutical synthesis rarely ask us about the theoretical applications of D-(-)-A-4-Hydroxyphenylglycine Dane Salt Methyl Potassium. They know where it fits—in the construction of specific cephalosporin and penem antibiotics, for the assembly of advanced peptides, and in the production of protected intermediates that move projects forward from gram scale to pilot plant. In academic settings, researchers deploy this salt for enantioselective synthesis trials or as a benchmark in methodology development. The chemical’s selection often reflects the drive to troubleshoot steps like acylation or condensation, where steric bulk and ion content matter deeply to yield and selectivity.
Patents and scientific publications referencing this compound rarely note the full complexity of what goes wrong when material falls out of spec. Our technicians have seen research records where a simple drop in stereochemical purity led a whole project to a dead end. We have learned from customer plant managers who traced recurring failures not to reagent price, but to loss of salt form stability during storage. This motivates our efforts to deliver all batches in packaging that survives international shipment, avoids container interactions, and resists temperature and humidity swings.
In the toolbox of functionalized glycine derivatives, the choice of salt form tilts the balance between ease of handling, solubility profile, and chemical stability. We prioritize the potassium salt due to its unique balance—offering high aqueous solubility, limited hygroscopicity, and minimal cation exchange challenges in downstream steps. Several users find potassium salts less reactive toward resin or silica adsorption, which proves useful for peptide synthesis operations and for pilot scale chromatography setups. Our real experience matches these findings: potassium Dane salts maintain their defined composition through long transfers and recirculation, which reduces end-stage variability.
The methyl ester variation, produced by our lines with closely regulated temperature and catalyst feeds, allows for predictable deprotection and coupling strategies downstream. Many pharmaceutical teams prefer the methyl ester to ethyl or tert-butyl counterparts, finding that it introduces less risk of unwanted rearrangement or dealkylation under basic or acid-labile protection protocols. Such details have emerged not from equipment manuals, but from repeated cycles of customer troubleshooting—sometimes even from direct site visits, where we saw, with our own eyes, pipes clogged by the wrong salt form after a change in upstream supplier.
The world of chemical manufacturing has changed in the decades our operation has supplied D-(-)-A-4-Hydroxyphenylglycine Dane Salt Methyl Potassium. Growth in demand, stricter regulatory frameworks, and increasingly differentiated downstream products have forced every producer to raise their game. Newcomers often underestimate the gap between business development promises and real production results. We watch many firms offer laboratory-scale material at prices and timelines that never hold up when real orders for tens or hundreds of kilos arrive. Chemists using our product on scale expect more than a signature on a certificate—they want support to track and solve the real-world quirks that only appear during scale-up, re-crystallization, or long-haul shipping.
Feedback loops run deep in our plant. We keep direct lines open to every team receiving our batches. One customer told us that problematic micro-impurities in Dane salt methyl potassium precipitated as “sticky residues” during scale-up filtration. In response, our process team studied the micron-size dust profile and adapted the filtration and packing process. Such deep dives are the norm, not the exception, for manufacturers managing a chemically active intermediate that ends up inside life-saving drugs.
Looking at various hydroxyphenylglycine derivatives, including sodium or ammonium salts and their ethyl or tert-butyl esters, we notice distinctions that matter more in the daily workflow than any generic product brochure admits. Sodium forms often bring higher hydration risks and, for certain chromatographic steps, more cation interference. Ammonium salt variants release ammonia over time if exposed to air, driving shifts in local pH and impacting forward integration steps. Our choice and recommendation for potassium derivatives come from long-term observation: potassium salts simplify many day-to-day problems—from adjusting buffer compatibility in peptide assembly, to storing large inventory blocks for long periods.
End-users continually report improved control when dosing, as potassium Dane salts handle well in automated feeding systems. Our own staff have clocked the time difference and spill rates when switching between less stable salts that either clump, degrade, or begin to absorb moisture after brief air exposure. Facilities running continuously benefit from our critical point packaging designs that reduce the need to break seal repeatedly, protecting product value and process safety.
Lining up esters side by side, experience shows the methyl ester behaves more predictably under classical deprotection conditions—key for scaling proven recipes up to industrial reactors. While tert-butyl esters bring theoretical protection in some specialty applications, they often require harsher deprotection that is less desirable at scale. Methyl potassium in the Dane salt configuration, according to records from our QC and stories from our partners in synthesis, achieves the right middle ground for broad utility.
Behind each bag of our D-(-)-A-4-Hydroxyphenylglycine Dane Salt Methyl Potassium stands not just our operators, but the safety and environmental teams watching every stage. It is easy to talk about compliance, but at our scale, culture trumps paperwork. Our people catch issues early: a small fume at the coupling reactor, a tiny leak at the dryer, or minor shifts in exhaust stack pH readings lead to real human interventions long before any outside audit might catch something amiss.
Waste streams from manufacturing this class of chemical pass through multiple treatment stages. Acidic and basic washes, mother liquors, and bulk container rinse waters are neutralized, tested, and, if needed, further detoxified before discharge. We do not see these steps as a burden. Acting as a direct supplier for many global clients, our plant’s reputation travels with every kilogram shipped. Our process and environmental engineers review both global and local regulations and have set up routine third-party audits so that our customers down the line do not deal with regulatory surprises.
We owe our improvements in safety to the simple practice of keeping the process team on the floor to watch real reactions—not just collecting charts in a remote office. Call it an old-school approach, but it works—more eyes on run tanks, more ears open to reaction sounds, fewer surprises. This boots-on-the-ground culture helped us pass every third-party review and prevents process drift, which protects the purity and reputation of every lot produced.
Our most valued relationships develop from shared troubleshooting and mutual accountability. One of our earliest pharmaceutical clients struggled with a batch of D-(-)-A-4-Hydroxyphenylglycine Dane Salt Methyl Potassium from a competitor that arrived clumped and off-color, traced later to improper drying and cross-contamination during packing. We spent days on-site with their chemists, reverse-engineering the root cause, and then supplied a couple of fresh lots prepared with incremental process improvements. The client’s subsequent batch ran cleaner, finished ahead of schedule, and led to life-long collaboration between our tech leads and their R&D team.
Through these experiences, we have learned that beyond molecular diagrams and certificates, it is the manufacturer’s track record on transparency and responsiveness that builds credibility. The best product spec cannot salvage goodwill if question emails go unanswered or if technical team members are unavailable to talk through unanticipated process failures. By comparison, direct operators—the ones writing shift notes and troubleshooting glassware blockages—offer insights hard to replicate in any script.
The journey with D-(-)-A-4-Hydroxyphenylglycine Dane Salt Methyl Potassium continues well beyond quarterly batch reports. Customers’ requests drive us towards higher levels of purity, greater batch-to-batch reproducibility, and safer, greener manufacturing. Our process team invests in pilot-scale testing of solvent recycling systems, emission-reduced reactors, and next-generation drying technology to deliver more product with fewer environmental trade-offs.
By collaborating directly with formulation chemists, we engineer packaging that simplifies warehouse logistics for end-users—shifting from traditional fiber drums to moisture-barrier, tamper-proof containers that endure cold chain and hot climates alike. Each adjustment—born from factory-floor learning and customer commentary—translates into a more reliable journey from our reactors to the final formulation lab.
With regulatory and pharmacovigilance requirements rising each year, our regulatory team works hand-in-hand with R&D chemists and operations managers. They cross-check material compliance and help produce documentation in line with both current and anticipated global standards. Origin-to-destination traceability, on-demand COAs, and detailed supply chain audits all stem not from corporate policy but from real, sometimes painful, history of what happens when documentation lags behind reality.
D-(-)-A-4-Hydroxyphenylglycine Dane Salt Methyl Potassium stands as both a technical product and a story of people, experience, mistakes, and hard-earned improvement. It does not exist simply as a bullet point in a catalog. Our years making, testing, and shipping it have forged a way of working that values both the needs of pilot plant operators troubleshooting an unpredictable coupling and the daily reality of academic chemists who run small-batch reaction screens. Most customers have seen the difference between manufacturer-supplied and broker-repackaged goods not by reading SDSs, but through the reality of project performance on tight deadlines.
For us, each acceptance and each complaint go into an ongoing conversation—a feedback system pushing us relentlessly toward better product and service. This cycle has enabled our continuous improvements. Knowledge gained from one difficult lot or shipping delay shapes the next round of process upgrades.
Ultimately, D-(-)-A-4-Hydroxyphenylglycine Dane Salt Methyl Potassium is more than an intermediate. In our shop, every order, every lot number, and every customer inquiry fuels the drive for precision, safety, and enduring collaboration—qualities rooted not in slogans, but in the lived, practical challenges of chemical manufacturing.